MACACA FASCICULARIS SUSCEPTIBILITY TO RT-SHIV FOLLOWING INTRAVAGINAL INOCULATION
阴道内接种后食管猴对 RT-SHIV 的敏感性
基本信息
- 批准号:7958878
- 负责人:
- 金额:$ 33.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAntibody FormationBloodCD4 Positive T LymphocytesComputer Retrieval of Information on Scientific Projects DatabaseDNADoseEvaluationExhibitsFundingGrantHIVHIV InfectionsHIV-1HIV-1 Reverse TranscriptaseHumanImmunologicsIn VitroInstitutionMacacaMacaca fascicularisMacaca nemestrinaMethodsModelingMonitorPathogenicityPeripheral Blood Mononuclear CellPlasmaPredispositionPreventivePrimatesRNA-Directed DNA PolymeraseResearchResearch PersonnelResourcesSourceSystemic infectionTherapeuticUnited States National Institutes of HealthViral AntibodiesViremiaVirusnon-nucleoside reverse transcriptase inhibitorspreclinical evaluationresponsetransmission processvaginal transmission
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Background The reverse transcriptase (RT) of the human immunodeficiency virus (HIV-1)
is a major target for controlling HIV infection and/or acquired immunodeficiency syndrome (AIDS) in humans. Suitable macaque model is urgently needed for the evaluation of HIV preventive and therapeutic strategies specifically targeting HIV-1 RT. We have characterized a CCR5-trpoic SIV/HIV-RT chimeric virus (RT-SHIVtc) which exhibited high in vitro sensitivity to nonnucleoside RT inhibitors and is highly pathogenic to mucosal transmission in pigtail macaques. This virus was used to carry out an infectious dose determining study by vaginal transmission in cynomolgus macaques (Macaca fascicularis) which are relatively less expensive and more readily available than other macaques. Methods Fifteen healthy cynomolgus macaques were randomly divided into three groups (n = 5) and intravaginally inoculated with 4,800, 1,200 or 300 TCID50 of RT-SHIVtc. Systemic infections of RT-SHIVtc exposed macaques were monitored by determining both virological findings and immunologic responses during 24 weeks post challenge. Results Within two weeks post inoculation (PI), all five macaques inoculated with the highest dose and four of five macaques inoculated with either medium or the lowest dose, were systemically infected as determined by the isolation of infectious virus and presence of proviral DNA in PBMC and the high level of persistent plasma viremia. All the infected macaques exhibited antiviral antibody response and most of the viremic macaques showed declined CD4+T cells in their blood. Conclusions Our results serve to validate the pathogenicity of RT-SHIVtc mucosal transmission in M. fascicularis. This new macaque model will be very useful for the preclinical evaluation of candidate HIV-1 nonnucleoside RT inhibitors (NNRTI).
这个子项目是许多利用
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
背景 人类免疫缺陷病毒(HIV-1)的逆转录酶(RT)
是控制人类HIV感染和/或获得性免疫缺陷综合征(AIDS)的主要目标。合适的猕猴模型是迫切需要的艾滋病预防和治疗策略,特别是针对HIV-1 RT的评估。我们已经确定了CCR5-trpoic SIV/HIV-RT嵌合病毒(RT-SHIVtc),表现出高敏感性的非核苷类RT抑制剂在体外和高致病性的粘膜传播的猪尾猕猴。该病毒用于在食蟹猴(Macaca fascicularis)中通过阴道传播进行感染剂量确定研究,食蟹猴比其他猕猴相对便宜且更容易获得。 方法 将15只健康食蟹猴随机分为3组(n = 5),阴道内接种4,800、1,200或300 TCID50的RT-SHIVtc。通过测定攻毒后24周期间的病毒学结果和免疫学应答,监测RT-SHIVtc暴露猕猴的全身感染。 结果 接种后2周内(PI),通过分离感染性病毒和PBMC中存在前病毒DNA以及高水平的持续性血浆病毒血症确定,接种最高剂量的所有5只猕猴和接种中等或最低剂量的4/5只猕猴全身感染。所有感染猕猴均表现出抗病毒抗体应答,大多数病毒血症猕猴血液中CD4 + T细胞下降。结论 我们的研究结果证实了RT-SHIVtc在M.束状肌这种新的猕猴模型将是非常有用的候选HIV-1非核苷RT抑制剂(NNRTI)的临床前评价。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Che-Chung Tsai其他文献
Che-Chung Tsai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Che-Chung Tsai', 18)}}的其他基金
PRIMATE MODELS FOR HIV PREVENTION AND THERAPEUTIC STRATEGIES
HIV 预防和治疗策略的灵长类动物模型
- 批准号:
8172793 - 财政年份:2010
- 资助金额:
$ 33.14万 - 项目类别:
VAGINAL TRANSMISSION OF A PATHOGENIC RT-SHIVTC IN CYNOMOLGUS MACAQUES
食蟹猴中致病性 RT-SHIVTC 的阴道传播
- 批准号:
8172794 - 财政年份:2010
- 资助金额:
$ 33.14万 - 项目类别:
IN VIVO ADAPTATION OF SHIVSF162P3 IN PIGTAILED MACAQUES
SHIVSF162P3 在斑尾猕猴体内的适应性
- 批准号:
7165808 - 财政年份:2005
- 资助金额:
$ 33.14万 - 项目类别:
INDUCTION OF CHRONIC SIVMNE INFECTION IN MACAQUES
猕猴慢性丝虫感染的诱导
- 批准号:
7165839 - 财政年份:2005
- 资助金额:
$ 33.14万 - 项目类别:
CLINICAL PHARMACOKINETICS AND/OR TOXICITY STUDIES OF ANTI-HIV-AGENTS FOR MACAQUE
猕猴抗 HIV 药物的临床药代动力学和/或毒性研究
- 批准号:
7165838 - 财政年份:2005
- 资助金额:
$ 33.14万 - 项目类别:
CYANOVIRIN-N A MICROBICIDE PREVENTS RECTAL TRANSMISSION
Cyanovirin-N 杀菌剂可预防直肠传播
- 批准号:
6971721 - 财政年份:2004
- 资助金额:
$ 33.14万 - 项目类别:
SPL7013 GELS AS MICROBICIDE INHIBIT VAGINAL TRANSMISSION OF SHIV89.6P IN MACAQUE
SPL7013 凝胶作为杀菌剂抑制猕猴中 SHIV89.6P 的阴道传播
- 批准号:
6971719 - 财政年份:2004
- 资助金额:
$ 33.14万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 33.14万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 33.14万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 33.14万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 33.14万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 33.14万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 33.14万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 33.14万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 33.14万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 33.14万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 33.14万 - 项目类别: